Blue Trust Inc. Sells 900 Shares of Ingevity Co. (NYSE:NGVT)

Blue Trust Inc. lowered its position in Ingevity Co. (NYSE:NGVT) by 35.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,605 shares of the company’s stock after selling 900 shares during the period. Blue Trust Inc.’s holdings in Ingevity were worth $65,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of NGVT. Empowered Funds LLC purchased a new stake in Ingevity during the 4th quarter valued at approximately $187,000. KBC Group NV grew its stake in Ingevity by 27.5% during the fourth quarter. KBC Group NV now owns 2,007 shares of the company’s stock valued at $82,000 after acquiring an additional 433 shares in the last quarter. Mitsubishi UFJ Asset Management UK Ltd. purchased a new position in Ingevity during the fourth quarter valued at $530,000. Hennion & Walsh Asset Management Inc. bought a new stake in Ingevity in the 4th quarter valued at $239,000. Finally, Moody National Bank Trust Division lifted its stake in Ingevity by 12.4% in the 4th quarter. Moody National Bank Trust Division now owns 41,837 shares of the company’s stock worth $1,705,000 after purchasing an additional 4,608 shares in the last quarter. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on NGVT shares. BMO Capital Markets raised their price objective on Ingevity from $61.00 to $62.00 and gave the company a “market perform” rating in a research report on Thursday, February 20th. StockNews.com upgraded Ingevity from a “hold” rating to a “buy” rating in a report on Thursday, February 20th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Ingevity currently has an average rating of “Moderate Buy” and an average target price of $54.67.

Ingevity Trading Up 0.2 %

NGVT opened at $46.11 on Tuesday. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.29. The company has a current ratio of 1.87, a quick ratio of 1.04 and a debt-to-equity ratio of 6.86. The stock has a 50-day moving average of $43.36 and a 200 day moving average of $41.25. The firm has a market cap of $1.68 billion, a P/E ratio of -3.89 and a beta of 1.64.

Ingevity (NYSE:NGVT) last announced its earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.66. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The firm had revenue of $298.80 million during the quarter, compared to analysts’ expectations of $297.40 million. As a group, research analysts forecast that Ingevity Co. will post 4.45 EPS for the current year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.